Morgan Stanley Increases MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKKGY) Price Target to €198.00

MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKKGYGet Rating) had its price target upped by Morgan Stanley from €195.00 ($201.03) to €198.00 ($204.12) in a research note published on Friday, The Fly reports. They currently have an equal weight rating on the stock.

MKKGY has been the subject of a number of other reports. Barclays lowered their target price on MERCK Kommanditgesellschaft auf Aktien from €210.00 ($216.49) to €200.00 ($206.19) and set an overweight rating for the company in a report on Wednesday, November 2nd. Deutsche Bank Aktiengesellschaft lowered their target price on MERCK Kommanditgesellschaft auf Aktien from €248.00 ($255.67) to €220.00 ($226.80) and set a buy rating for the company in a report on Monday, October 10th.

MERCK Kommanditgesellschaft auf Aktien Trading Up 3.2 %

Shares of MKKGY stock opened at $37.64 on Friday. The stock has a 50 day simple moving average of $33.18 and a two-hundred day simple moving average of $34.85. MERCK Kommanditgesellschaft auf Aktien has a fifty-two week low of $30.16 and a fifty-two week high of $52.29.

About MERCK Kommanditgesellschaft auf Aktien

(Get Rating)

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology.

Read More

The Fly logo

Receive News & Ratings for MERCK Kommanditgesellschaft auf Aktien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MERCK Kommanditgesellschaft auf Aktien and related companies with MarketBeat.com's FREE daily email newsletter.